Esan Pharmaceuticals Private Limited
About Esan Pharmaceuticals Private Limited
Data last updated:
Esan Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 July 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74140DL2015PTC282830. Its GSTIN is 09AAECE0234B1ZA (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Anoop Kumar Mehrotra and Pulkit Khanna.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A13 Ff Block A Raju Park Khanpur, New Delhi, Delhi, India – 110062.
As per the financials filed for FY 2025, the company reported a revenue of ₹46.41 Lakh, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹65,651 (net margin 1.4%) and EBITDA of ₹3.37 Lakh (EBITDA margin 7.3%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 3% over five years.
As per MCA filings, the company has open charges of ₹19.35 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Esan Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA13 Ff Block A Raju Park Khanpur, New Delhi, Delhi, India – 110062
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Esan Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Esan Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Esan Pharmaceuticals Private Limited, buy the company report.
Financials of Esan Pharmaceuticals Private Limited
FY 2025 filings availableEsan Pharmaceuticals Private Limited reported revenue of ₹46.41 Lakh (down 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 11% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.37 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹65,651 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.3% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Esan Pharmaceuticals Private Limited, buy the company report.
Board of directors of Esan Pharmaceuticals Private Limited
Esan Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anoop Kumar Mehrotra | Director | 15 Jul 2015 | 11 Years 3 Months | Current |
| Pulkit Khanna | Director | 15 Jul 2015 | 11 Years 3 Months | Current |
| Ekta Mehrotra | Director | 15 Jul 2015 | 11 Years 3 Months | Current |
| Deepa Khanna | Director | 15 Jul 2015 | 11 Years 3 Months | Current |
Peer comparison
Esan Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Edvenswa Pharmaceuticals Private Limited | ₹46.5 Lakh (FY 2025) | -9.0% | Hyderabad, Telangana, India | |||
| Ramdular Pharmaceutical Private Limited | ₹46.44 Lakh (FY 2024) | 7.0% | Ratnagiri, Maharashtra, India | |||
| Esan Pharmaceuticals Private Limitedthis company | ₹46.41 Lakh (FY 2025) | ₹65,651 | 1.4% | -11.0% | New Delhi, Delhi, India | |
| Prolific Labs Private Limited | ₹46.34 Lakh (FY 2024) | -16.0% | New Delhi, Delhi, India | |||
| Esken Pharmaceuticals Limited | ₹46.28 Lakh (FY 2024) | 26.0% | Gujarat, India |
To see the full peer comparison of Esan Pharmaceuticals Private Limited, buy the company report.
Auditor
Esan Pharmaceuticals Private Limited is audited by SIDDHARTH GUPTA & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SIDDHARTH GUPTA & CO | FY 2019 | 020222C |
Shareholding
The shareholding of Esan Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Esan Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Sep 2017 | 100132803 | Indian Overseas Bank | ₹19.35 Lakh | Open |
To see the full charge records of Esan Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Esan Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Esan Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Esan Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECE0234B1ZA | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Esan Pharmaceuticals Private Limited, buy the company report.
Recent activity
Esan Pharmaceuticals Private Limited has 4 board changes on record since 2015: 4 appointments. The latest: Anoop Kumar Mehrotra was appointed as Director on 15 Jul 2015.
Frequently asked questions
Esan Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 July 2015 (11+ years old) and is registered under CIN U74140DL2015PTC282830.
Esan Pharmaceuticals has 4 current directors:
- Anoop Kumar Mehrotra - Director
- Pulkit Khanna - Director
- Ekta Mehrotra - Director
- Deepa Khanna - Director
The latest financial statements of Esan Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Esan Pharmaceuticals is 09AAECE0234B1ZA, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Esan Pharmaceuticals is U74140DL2015PTC282830. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Esan Pharmaceuticals was incorporated on 15 July 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Esan Pharmaceuticals by revenue are Edvenswa Pharmaceuticals Private Limited, Ramdular Pharmaceutical Private Limited, Prolific Labs Private Limited, Esken Pharmaceuticals Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anoop Kumar Mehrotra was appointed as Director on 15 Jul 2015. Deepa Khanna was appointed as Director on 15 Jul 2015. Ekta Mehrotra was appointed as Director on 15 Jul 2015. Esan Pharmaceuticals has 4 board changes on record in total.
The registered office of Esan Pharmaceuticals is at A13 Ff Block A Raju Park Khanpur, New Delhi, Delhi, India – 110062.
Esan Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Esan Pharmaceuticals has open charges of ₹19.35 Lakh and no satisfied charges on record as per latest MCA filings.